Sun Pharma.Inds.

{
  "main_header": {
    "sid": 948699,
    "name": "Sun Pharma.Inds.",
    "stock_name": "Sun Pharma.Inds.",
    "full_name": "Sun Pharmaceutical Industries Ltd",
    "name_url": "stocks-analysis/sun-pharmainds",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,906.65",
    "chg": 35.1,
    "chgp": "1.88%",
    "dir": 1,
    "prev_price": "1,871.55",
    "mcapval": "457,469.20 Cr",
    "mcap": "Large Cap",
    "scripcode": 524715,
    "symbol": "SUNPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE044A01036",
    "curr_date": "Jul 03, 03:17 PM",
    "curr_time": "15:18 PM",
    "last_traded_at": "Jul 03, 03:17 PM IST",
    "bse_nse_vol": "20.67 lacs",
    "exc_status": "Active",
    "traded_date": "Jul 03, 2026",
    "traded_date_str": "2026 07 03",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MS",
      "url": "https://www.marketsmojo.com/mojostocks#!#top10",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Rs 1,900 Puts — Just Below Current Price — Draw 4,257 Contracts on Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-surge-in-put-option-activity-amid-bullish-price-momentum-4087821",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SunPharmaceutic_most_active_stocks_puts_4087821.png",
        "date": "2026-07-03 12:00:07",
        "description": "The stock is trading at Rs 1,914.20, just above the Rs 1,900 put strike where 4,257 contracts changed hands on 3 July 2026. This close proximity between strike and underlying price suggests the put activity is more nuanced than a straightforward bearish bet."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Sun Pharmaceutical Industries Ltd to 52-Week High of Rs 1919.7",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-hits-new-52-week-high-at-rs-19197-4087780",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SunPharmaceutic_priceRelatedfactors_4087780.png",
        "date": "2026-07-03 11:11:35",
        "description": "With a decisive surge to Rs 1919.7 on 3 Jul 2026, Sun Pharmaceutical Industries Ltd has reached a fresh 52-week high, extending its upward momentum amid a broadly positive market backdrop."
      },
      {
        "title": "Rs 1900 Calls on Sun Pharmaceutical Industries Ltd See Heavy Activity — What the Strike Price Tells You",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-surge-in-call-option-activity-ahead-of-july-expiry-4087527",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SunPharmaceutic_most_active_stocks_calls_4087527.png",
        "date": "2026-07-03 10:00:26",
        "description": "4,102 call contracts at the Rs 1900 strike traded on 3 Jul 2026, with Sun Pharmaceutical Industries Ltd closing at Rs 1904.20, just above the strike price. This alignment between the options strike and the underlying price highlights a focused directional bet as the stock edges closer to its 52-week high."
      },
      {
        "title": "P/E at 36.01 vs Industry's 35.12: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strengthens-position-as-a-key-nifty-50-constituent-amid-institutional-interest-4087167",
        "imagepath": "",
        "date": "2026-07-03 09:21:57",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium Reflects Confidence Amid Sector Parity</strong></p>\n                <p>The current P/E of <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> stands at 36.01, slightly above the Pharmaceuticals & Biotechnology industry average of 35.12. This 2.5% premium suggests investors are willing to pay a marginally higher price for earnings, reflecting expectations of relative stability or growth within a sector that has seen mixed results. The premium is not excessive but indicates a degree of confidence in the company’s earnings quality and future prospects. <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharma</a>’s market capitalisa..."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sun-pharmaceutical-industries-ltd-is-rated-buy-4084701",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SunPharmaceutic_mojoScore_4084701.png",
        "date": "2026-07-02 10:10:53",
        "description": "Sun Pharmaceutical Industries Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 July 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "P/E at 35.98 vs Industry's 34.99: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strengthens-position-as-key-nifty-50-constituent-amid-robust-institutional-interest-4084300",
        "imagepath": "",
        "date": "2026-07-02 09:21:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Slight Premium Reflects Market Confidence</strong></p>\n                <p>The current P/E of 35.98 represents a modest premium of approximately 2.8% over the industry average of 34.99. This premium suggests that investors are willing to pay slightly more for <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> relative to its peers, possibly reflecting expectations of stable earnings growth or superior market positioning. However, the premium is not excessive, indicating that valuation remains broadly in line with sector norms. The market capitalisation of Rs 4,50,007.27 crore firmly places the company in the large-cap category, underscoring its established presence in the Pharmaceu..."
      },
      {
        "title": "Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amid Bullish Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-sees-significant-open-interest-surge-amid-bullish-market-signals-4081965",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SunPharmaceutic_oi_spurts_by_underlying_4081965.png",
        "date": "2026-07-01 15:00:27",
        "description": "Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest (OI) in its derivatives segment, reflecting heightened market activity and a potential shift in investor sentiment. The 12.5% increase in OI, coupled with robust volume and price momentum, suggests growing bullish positioning among traders, reinforcing the stock’s strong fundamentals and technical outlook."
      },
      {
        "title": "Sun Pharmaceutical Industries Sees Sharp Open Interest Surge Signalling Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-sees-sharp-open-interest-surge-signalling-bullish-market-positioning-4081893",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SunPharmaceutic_oi_spurts_by_underlying_4081893.png",
        "date": "2026-07-01 14:00:20",
        "description": "Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased investor participation and potential directional bets. The stock’s strong performance, coupled with rising volumes and improved market positioning, underscores growing bullish sentiment in the pharmaceuticals sector."
      },
      {
        "title": "Sun Pharmaceutical Sees Significant Open Interest Surge Signalling Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-significant-open-interest-surge-signalling-bullish-market-positioning-4081835",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SunPharmaceutic_oi_spurts_by_underlying_4081835.png",
        "date": "2026-07-01 13:00:25",
        "description": "Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent performance, combined with rising volumes and improved investor positioning, suggests a bullish sentiment taking hold in the pharmaceuticals sector."
      }
    ],
    "total": 1174,
    "sid": "948699",
    "stock_news_url": "https://www.marketsmojo.com/news/sun-pharmaceutical-industries-948699"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "26-Jun-2026",
      "details": "Newspaper Advertisement",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Jun-2026",
      "details": "Closure of trading window",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
      "datetime": "20-Jun-2026",
      "details": "Acquisition of Innovcare Lifesciences Private Limited",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has declared <strong>500%</strong> dividend, ex-date: 07 Jul 26",
          "dt": "2026-07-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:5</strong> stock split, ex-date: 25 Nov 10",
          "dt": "2010-11-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Jul 13",
          "dt": "2013-07-29",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Rs 1,900 Puts — Just Below Current Price — Draw 4,257 Contracts on Sun Pharmaceutical Industries Ltd

2026-07-03 12:00:07

The stock is trading at Rs 1,914.20, just above the Rs 1,900 put strike where 4,257 contracts changed hands on 3 July 2026. This close proximity between strike and underlying price suggests the put activity is more nuanced than a straightforward bearish bet.

Read full news article

Broad-Based Technical Strength Lifts Sun Pharmaceutical Industries Ltd to 52-Week High of Rs 1919.7

2026-07-03 11:11:35

With a decisive surge to Rs 1919.7 on 3 Jul 2026, Sun Pharmaceutical Industries Ltd has reached a fresh 52-week high, extending its upward momentum amid a broadly positive market backdrop.

Read full news article

Rs 1900 Calls on Sun Pharmaceutical Industries Ltd See Heavy Activity — What the Strike Price Tells You

2026-07-03 10:00:26

4,102 call contracts at the Rs 1900 strike traded on 3 Jul 2026, with Sun Pharmaceutical Industries Ltd closing at Rs 1904.20, just above the strike price. This alignment between the options strike and the underlying price highlights a focused directional bet as the stock edges closer to its 52-week high.

Read full news article

P/E at 36.01 vs Industry's 35.12: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-07-03 09:21:57

Valuation Picture: Premium Reflects Confidence Amid Sector Parity

The current P/E of Sun Pharmaceutical Industries Ltd stands at 36.01, slightly above the Pharmaceuticals & Biotechnology industry average of 35.12. This 2.5% premium suggests investors are willing to pay a marginally higher price for earnings, reflecting expectations of relative stability or growth within a sector that has seen mixed results. The premium is not excessive but indicates a degree of confidence in the company’s earnings quality and future prospects. Sun Pharma’s market capitalisa...

Read full news article

Sun Pharmaceutical Industries Ltd is Rated Buy

2026-07-02 10:10:53

Sun Pharmaceutical Industries Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 July 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Read full news article

P/E at 35.98 vs Industry's 34.99: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-07-02 09:21:16

Valuation Picture: Slight Premium Reflects Market Confidence

The current P/E of 35.98 represents a modest premium of approximately 2.8% over the industry average of 34.99. This premium suggests that investors are willing to pay slightly more for Sun Pharmaceutical Industries Ltd relative to its peers, possibly reflecting expectations of stable earnings growth or superior market positioning. However, the premium is not excessive, indicating that valuation remains broadly in line with sector norms. The market capitalisation of Rs 4,50,007.27 crore firmly places the company in the large-cap category, underscoring its established presence in the Pharmaceu...

Read full news article

Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amid Bullish Market Signals

2026-07-01 15:00:27

Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest (OI) in its derivatives segment, reflecting heightened market activity and a potential shift in investor sentiment. The 12.5% increase in OI, coupled with robust volume and price momentum, suggests growing bullish positioning among traders, reinforcing the stock’s strong fundamentals and technical outlook.

Read full news article

Sun Pharmaceutical Industries Sees Sharp Open Interest Surge Signalling Bullish Market Positioning

2026-07-01 14:00:20

Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased investor participation and potential directional bets. The stock’s strong performance, coupled with rising volumes and improved market positioning, underscores growing bullish sentiment in the pharmaceuticals sector.

Read full news article

Sun Pharmaceutical Sees Significant Open Interest Surge Signalling Bullish Market Positioning

2026-07-01 13:00:25

Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent performance, combined with rising volumes and improved investor positioning, suggests a bullish sentiment taking hold in the pharmaceuticals sector.

Read full news article

View All News